| B13 | Reaching HCV micro-elimination in HIV/HCV co-infected individuals in the Netherlands: exploring remaining barriers to HCV treatment | On-demand oral abstract session | Viral hepatitis C |
| B13 | Evaluation of the HCV cascade of care among people with HIV/hepatitis C co-infection in New South Wales, Australia: a data linkage study | On-demand oral abstract session | Viral hepatitis C |
| B11 | Outcomes and incidence of TB among people living with HIV who received TB preventive therapy in Uganda | On-demand oral abstract session | Tuberculosis and other mycobacteria |
| B3 | The clinical effects of durably low CD4 counts while virologically suppressed among ART-initiating persons with HIV in Latin America | On-demand oral abstract session | Determinants of HIV progression and disease control |
| B11 | Correlates associated with mortality among HIV-TB co-infected patients in Mumbai, India | On-demand oral abstract session | Tuberculosis and other mycobacteria |
| B11 | Long-term survival and predictors of mortality in HIV/TB patients in Uganda | On-demand oral abstract session | Tuberculosis and other mycobacteria |
| B68 | Incidence and co-factors of Mtb infection in first 2 years of life: observational follow-up of a randomized controlled trial of INH to prevent primary Mtb infection among HIV-exposed uninfected children | On-demand oral abstract session | HIV-exposed uninfected children |
| B35 | Comparison of viral replication for the 2-drug regimen (2DR) of dolutegravir/lamivudine (DTG/3TC) versus a 3/4-drug tenofovir alafenamide'based regimen (TBR) in the TANGO study through week 96 | On-demand oral abstract session | Regimen simplification and switch studies |
| B39 | Week 124 results of the randomized, open-label, Phase 3 FLAIR study evaluating long-acting cabotegravir + rilpivirine for treatment in adults with HIV-1 infection (ITT-E population) | On-demand oral abstract session | Long-acting agents and other drug delivery systems |
| B35 | Prevalence of baseline virological risk factors of increased virological failure to CAB+RPV among ARV-naïve patients | On-demand oral abstract session | Regimen simplification and switch studies |